Responsum Health Partners with Citeline Connect to Expand Clinical Trial Access for Its Community Members
Responsum Health expands access to clinical trials to its thousands of community members.
[WASHINGTON, D.C., March 21, 2022]— Responsum Health is excited to announce that it has signed an agreement with Citeline Connect to identify and share clinical trial opportunities with members of its various online communities, including chronic kidney disease and long COVID.
This important and promising relationship will allow Responsum to better serve its community members by providing access to one of the leading clinical trial platforms in the country. It also gives Responsum a new means of sustaining its free family of knowledge apps for individuals living with chronic health issues.
Citeline Connect is a collective that powers smarter, simpler patient referrals for clinical trials. The platform enables sponsors to securely share clinical trial data and recruitment opportunities with a vetted network of patient recruitment companies, healthcare organizations, and patient advocacy groups. It bridges the gap between Citeline Connect-coordinated clinical trials in search of patients and healthcare organizations with patients looking for promising potential solutions for the management of their conditions.
“We are excited at another important partnership with a well-established healthcare partner that validates our company and its mission,” said CEO and Founder Andrew Rosenberg. “Citeline came to us because they were impressed with our ability to engage patients from across numerous chronic conditions, and we are all looking forward to a mutually beneficial collaboration.”
Responsum looks forward to linking its platform members to potentially life-changing clinical research toward the treatment and management of their conditions.
For more information contact Responsum Health via email at press@responsumhealth.com.
About Citeline Connect
Citeline Connect is an industry-first patient referral collective. It uses data, technology, and teamwork to better connect sponsors with a collective of recruitment partners to accelerate clinical trial enrollment in a pay-for-performance model. Its analysis, insight, and consultancy services span drug, device, company, clinical trial, and market intelligence. All services are delivered by an authoritative team of industry experts in key markets around the globe.
About Informa Pharma Intelligence
Informa Pharma Intelligence powers a full suite of analysis products — Datamonitor Healthcare™, Sitetrove™, Trialtrove™, Pharmaprojects™, Biomedtracker™, Scrip™, Pink Sheet™ and In Vivo™ — to deliver the data needed by the pharmaceutical and biomedical industry to make decisions and create real-world opportunities for growth.
With more than 400 analysts keeping their fingers on the pulse of the industry, no key disease, clinical trial, drug approval or R&D project isn’t covered through the breadth and depth of data available to customers. For more information, visit pharmaintelligence.informa.com.
About Responsum Health
With a mission of building and supporting online “knowledge communities” of chronic disease patients, Responsum Health (Latin for “the answer”) is a disruptive and innovative healthcare startup company that develops and provides free, disease-specific patient engagement platforms and apps that monitor, search, and curate the Internet – and then generate a personalized newsfeed of article summaries vetted by Responsum’s patient group and subject matter expert partners. For patients with chronic illness, Responsum Health replaces the need to sort and sift through the Internet on their own with a professionalized search and summary service; indeed, no other such app or platform exists.
Responsum Health wraps a proprietary newsfeed into a highly engaging digital platform that enables patients to comment on and rate the articles and share with their professional care team and loved ones. Responsum platforms also enable patients to share experiences through a moderated social wall, organize their health information, and find local patient support groups and services near them.
With dynamic patient knowledge platforms in areas as diverse as pulmonary fibrosis, chronic kidney disease, uterine fibroids, glaucoma, and long COVID, Responsum Health’s apps drive extremely high user engagement metrics that widely exceed industry standards. Developed from years of interviews, extensive research at Carnegie Mellon University, and collaboration with hundreds of patients worldwide, Responsum Health’s disease-specific apps are designed to improve patients’ knowledge, grow their self-confidence, and provide for the organization and coordination of their healthcare information. Today, thousands of patients and their caregivers rely on Responsum Health apps and content for their daily health information.
The company is a part of the Startup Health network of recognized healthcare innovators and counts leading corporations and organizations among its clients and partners in delivering knowledge platforms in areas as diverse as pulmonary fibrosis, chronic kidney disease, uterine fibroids, and glaucoma. Clients and partners of Responsum Health include Astellas, Otsuka, Abbvie, Galapagos, the Allergan Foundation, Prevent Blindness, the Pulmonary Fibrosis Foundation, The White Dress Project, the Black Women’s Health Imperative, and CARE About Fibroids.